THY1 and liver cancer: Some studies showed that CD133+ liver cancer cells are liver cancer stem cell [38], however, others suggested that CD90+ and CD44+ are the biomarkers of liver cancer stem cell [14].It is because of this, we had chosen as much more accepted and several related markers of liver cancer stem cells to confirm the presence of stemness.